A total error approach for the validation of quantitative analytical methods

被引:52
作者
Hoffman, David [1 ]
Kringle, Robert [1 ]
机构
[1] Sanofi Aventis, Bridgewater, NJ USA
关键词
analysis of variance; bioanalytical assay; method validation; tolerance interval; total error;
D O I
10.1007/s11095-007-9242-3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. Typical acceptance criteria for analytical methods are not chosen with regard to the concept of method suitability and are commonly based on ad-hoc rules. Such approaches yield unknown and uncontrolled risks of accepting unsuitable analytical methods and rejecting suitable analytical methods. This paper proposes a formal statistical framework for the validation of analytical methods, which incorporates the use of total error and controls the risks of incorrect decision-making. Materials and Methods. A total error approach for method validation based on the use of two-sided beta-content tolerance intervals is proposed. The performance of the proposed approach is compared to the performance of current ad-hoc approaches via simulation techniques. Results. The current ad-hoc approaches for method validation fail to control the risk of incorrectly accepting unsuitable analytical methods. The proposed total error approach controls the risk of incorrectly accepting unsuitable analytical methods and provides adequate power to accept truly suitable methods. Conclusion. Current ad-hoc approaches to method validation are inconsistent with ensuring method suitability. A total error approach based on the use of two-sided beta-content tolerance intervals was developed. The total error approach offers a formal statistical framework for assessing analytical method performance. The approach is consistent with the concept of method suitability and controls the risk of incorrectly accepting unsuitable analytical methods.
引用
收藏
页码:1157 / 1164
页数:8
相关论文
共 17 条
  • [1] An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: progresses and limitations
    Boulanger, B
    Chiap, P
    Dewe, W
    Crommen, J
    Hubert, P
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2003, 32 (4-5) : 753 - 765
  • [2] Burdick R., 1992, Confidence intervals on variance components, V1st
  • [3] Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules
    DeSilva, B
    Smith, W
    Weiner, R
    Kelley, M
    Smolec, JM
    Lee, B
    Khan, M
    Tacey, R
    Hill, H
    Celniker, A
    [J]. PHARMACEUTICAL RESEARCH, 2003, 20 (11) : 1885 - 1900
  • [4] Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective
    Findlay, JWA
    Smith, WC
    Lee, JW
    Nordblom, GD
    Das, I
    DeSilva, BS
    Khan, MN
    Bowsher, RR
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 21 (06) : 1249 - 1273
  • [5] *FOOD DRUG ADM, 2002, GUID IND AN PROC MET
  • [6] Hauck W W, 2001, J Biopharm Stat, V11, P335, DOI 10.1081/BIP-120008852
  • [7] Modified two-sided normal tolerance intervals for batch acceptance of dose uniformity
    Hauck, WW
    Shaikh, R
    [J]. PHARMACEUTICAL STATISTICS, 2004, 3 (02) : 89 - 97
  • [8] Two-sided tolerance intervals for balanced and unbalanced random effects models
    Hoffman, D
    Kringle, R
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2005, 15 (02) : 283 - 293
  • [9] Harmonization of strategies for the validation of quantitative analytical procedures -: A SFSTP proposal -: part I
    Hubert, P
    Nguyen-Huu, JJ
    Boulanger, B
    Chapuzet, E
    Chiap, P
    Cohen, N
    Compagnon, PA
    Dewé, W
    Feinberg, M
    Lallier, M
    Laurentie, M
    Mercier, N
    Muzard, G
    Nivet, C
    Valat, L
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 36 (03) : 579 - 586
  • [10] HUBERT P, 2006, STP PHARM PRATIQUES, V16, P28